本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BioRestorative Therapies, Inc.

2.67
-0.0900-3.26%
盤後2.710.0400+1.50%18:46 EDT
成交量:1.13萬
成交額:3.02萬
市值:368.76萬
市盈率:-0.13
高:2.78
開:2.75
低:2.63
收:2.76
52周最高:34.60
52周最低:2.61
股本:138.11萬
流通股本:124.91萬
量比:0.17
換手率:0.90%
股息:- -
股息率:- -
每股收益(TTM):-21.2000
每股收益(LYR):-31.6731
淨資產收益率:-241.14%
總資產收益率:-118.81%
市淨率:1.22
市盈率(LYR):-0.08

資料載入中...

2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/06

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/09/23

重要事件披露

Form 8-K - Current report
2024/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/08/06

重要事件披露

Form 8-K - Current report
2024/06/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/11

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/24

重要事件披露

Form 8-K - Current report
2024/04/17

SEC問詢函

Form CORRESP - Correspondence
2024/04/12

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/04/03

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/03/30

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/12

重要事件披露

Form 8-K - Current report
2024/03/06

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/15

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/15

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]